3 results
Primary objective: To evaluate the effect of navitoclax in combination with ruxolitinib on splenomegaly response when compared to ruxolitinib in subjects with myelofibrosis.Secondary objectives:• To evaluate the effect of navitoclax in combination…
PRIMARY: Dose finding part (Phase 1):To assess the safety and tolerability of durvalumab when given in combination with lenalidomide and rituximab; ibrutinib; or bendamustine and rituximab to determine the recommended Phase 2 doses (RP2Ds) of each…
Purpose of this descriptive study is to gauge the feasibility of the Q1.6 app as platform to measure gout flares in real time. Primary research question: What is the perceived patients* value of thirty patients of app-based platform Q1.6 for…